Enantioselectivity in estrogenic potential and uptake of bifenthrin.
Despite the fact that the biological processes of chiral compounds are enantioselective, the endocrine disruption activity and uptake of chiral contaminants with respect to enantioselectivity has so far received limited research. In this study, the estrogenic potential and uptake of the enantiomers of a newer pyrethroid insecticide, bifenthrin (BF), were investigated. Significant differences in estrogenic potential were observed between the two enantiomers in the in vitro human breast carcinoma MCF-7 cell proliferation assay (i.e., the E-SCREEN assay) and the in vivo aquatic vertebrate vitellogenin enzyme-linked immunosorbent assay (ELISA). In the E-SCREEN assay, the relative proliferative effect ratios of 1S-cis-BF and 1R-cis-BF were 74.2% and 20.9%, respectively, and the relative proliferative potency ratios were 10% and 1%, respectively. The cell proliferation induced by the two BF enantiomers may be through the classical estrogen response pathway via the estrogen receptor (ER), as the proliferation induced by the enantiomers could be completely blocked when combined with 10-6 mol/L of the ER antagonist ICI 182,780. Measurement of vitellogenin induction in Japanese medaka (Oryzias latipes) showed that, at an exposure level of 10 ng/mL, the response to 1S-cis-BF was about 123 times greater than thattothe Renantiomer. Significant selectivity also occurred in the uptake of BF enantiomers in the liver and other tissues of J. medaka. These results together suggest that assessment of the environmental safety of chiral insecticides should consider enantioselectivity in acute and chronic ecotoxicities such as endocrine disruption.
Wang
Lumei
L
Research Center of Environmental Science, Zhejiang University of Technology, Hangzhou 310032, China.
Liu
Weiping
W
Yang
Caixia
C
Pan
Zhiyan
Z
Gan
Jianying
J
Xu
Chao
C
Zhao
Meirong
M
Schlenk
Daniel
D
D000818:Animals; D001943:Breast Neoplasms / Q000473:pathology; D049109:Cell Proliferation / Q000187:drug effects*; D004797:Enzyme-Linked Immunosorbent Assay; D004967:Estrogens / Q000737:chemistry / Q000493:pharmacokinetics*; D005260:Female; D006801:Humans; D007306:Insecticides / Q000493:pharmacokinetics / Q000633:toxicity; D008099:Liver / Q000473:pathology; D009990:Oryzias / Q000378:metabolism*; D011722:Pyrethrins / Q000737:chemistry / Q000493:pharmacokinetics*; D011960:Receptors, Estrogen / Q000378:metabolism; D013237:Stereoisomerism; D014018:Tissue Distribution; D014407:Tumor Cells, Cultured; D014819:Vitellogenins / Q000032:analysis; D014874:Water Pollutants, Chemical / Q000737:chemistry / Q000493:pharmacokinetics*
D004967:Estrogens; D007306:Insecticides; D011722:Pyrethrins; D011960:Receptors, Estrogen; D014819:Vitellogenins; D014874:Water Pollutants, Chemical; C099952:bifenthrin